Welcome to the Pharma R&D Annual Review
For over 30 years, the Pharma R&D Annual Review has tracked how the climate is shifting, revealing the currents and tides that shape the drug development landscape.
This year, we’ve taken the industry’s temperature by analyzing over 22,000 drugs and examining pipeline by company, therapeutic area, disease, target, drug type, region and much more.
Browse our reports, infographics, audiobook and webinar below, to help you determine where the outlook is sunny, and where storm clouds are gathering.
New Active Substances Launched During 2023
Find out which new drugs made it to market in last year
Pharma R&D Annual Review 2024 Webinar
NOW AVAILABLE ON-DEMAND
Join the Citeline team for its long-running annual review of trends in pharma R&D. In this webinar, you will learn how the pharma R&D climate is changing, where the outlook is sunny and where storm clouds are gathering.
Register to gain access to the on-demand webinar so you can forecast for success in 2024.
Make the insights matter
Book a demo today
Learn more about our suite of solutions providing the industry's leading global R&D intelligence.
